I
nflammatory bowel disease (IBD) represents chronic complex disorders of the gastrointestinal tract, ulcerative colitis (UC) and Crohn's disease (CD), with highest incidence peak in fertile age. Several risk factors have been associated with adverse pregnancy outcomes in mothers with IBD, such as disease activity, 1,2 bowel resections, 3 and familial aggregation of IBD. 4 Although disease activity at conception and during pregnancy has been pointed out as the strongest predictor of adverse pregnancy outcomes in mothers with IBD, having IBD has been demonstrated as a risk factor on its own, independent of disease activity. 5, 6 The most consistent adverse outcomes described are preterm delivery (before 37 weeks of gestation), low birth weight (,2500 g), and small for gestational age (SGA) birth. [7] [8] [9] It is well known that adequate gestational weight gain (GWG) during pregnancy is essential for fetal development and growth. Several investigations have revealed an association between inadequate GWG and preterm birth or SGA babies in the general population. [10] [11] [12] The influence of GWG on pregnancy complications depends on the prepregnancy body mass index (BMI). The Institute of Medicine (IOM) has established guidelines for GWG according to prepregnancy BMI, 13 which has been adopted by the Norwegian directorate of health.
Patients with IBD are prone to weight loss and malnutrition, especially in periods with active disease, but also in remission. 14 Contributing factors to weight loss in remission are disease complications such as stenosis, bowel resections, and food restriction, especially dairy products, to avoid symptoms such as diarrhea and abdominal pain. [15] [16] [17] Only 2 small earlier studies have demonstrated an association between low GWG (,12 kg) and adverse perinatal outcomes in maternal IBD. 18, 19 We hypothesize that GWG works as an indirect or mediating factor between IBD and adverse pregnancy outcomes. Our aims were therefore to investigate the risk of inadequate GWG, and the impact of inadequate GWG on adverse pregnancy outcomes, among mothers with IBD compared with non-IBD mothers.
MATERIALS AND METHODS

The Norwegian Mother and Child Cohort
The Norwegian Mother and Child Cohort Study (MoBa) is a prospective population-based pregnancy cohort study conducted by the Norwegian Institute of Public Health. 20 The cohort now includes 114,500 children and 95,200 mothers recruited from all over Norway in the period 1999 to 2008. The women were included at 17 to 18 weeks of pregnancy, at the first ultrasound visit. Informed consent was obtained from all participants, and they were asked to fill out comprehensive questionnaires at regular intervals. The basic questionnaire (Q1), at week 17 to 18, shortly before the first ultrasound visit, included information of mothers' sociodemographic data, such as education, age, height, prepregnancy weight, and smoking history. Furthermore, they were asked about health, lifestyle, medication, and pregnancy complications. In the fourth questionnaire (Q4), 6 months postpartum, the participants were asked to record weight at delivery and at 6 months postpartum. In the GWG analyses, mothers with plural birth and GWG less than 30 kg and more than 50 kg were excluded from the analyses. Of the 739 mothers who claimed to have IBD in the basic questionnaire (Q1), only 655 mothers were still included in the ongoing MoBa cohort study and therefore available for this study. We mailed out a questionnaire in 2013 to obtain information about the IBD history and disease activity 4 weeks before pregnancy and during the pregnancy. Disease activity was graded on a scale of 1 to 4, from no symptoms to severe symptoms affecting daily activity with sick leave as a consequence. Furthermore, they were asked to report treatment consequences of flares with 3 options: change of medication, IBD-related surgery, or IBD-related hospital admissions. The fulfillment of at least one of these 3 options was defined as disease activity.
Based on a detailed questionnaire concerning their IBD history, of 328 responders, 136 mothers were considered to have CD and 192 to have UC disease. We connected the nonresponders (No ¼ 329) with the Norwegian Patient Registry to obtain information about the phenotype of IBD, CD, or UC. Of the nonresponders, 79 and 95 women were recorded as CD and UC in Norwegian Patient Registry. Both mothers with IBD who responded to the questionnaire and those who were registered in Norwegian Patient Registry as CD or UC were included in the study, 215 CD and 287 UC mothers. Only 166 mothers with CD and 217 mothers with UC were recorded with information of GWG and available for the GWG analyses (flowchart). The cohort was linked to the Medical Birth Registry of Norway.
Ethics
The study was approved by The Regional Committee for Medical Research Ethics in South-Eastern Norway.
Outcome Variables
SGA was defined as birth weight below the 10th percentile of population-based birth weight, based on sex and week of gestation. Preterm birth was defined as delivery at less than 37 weeks of gestation. Gestational age was based on the first trimester ultrasound, or the last menstrual period, if the measure from the ultrasound was missing.
Exposure Variable
GWG was based on self-reported prepregnant weight recorded in the basic questionnaire (Q1) and self-reported weight at delivery recorded in the fourth questionnaire 6 months after 
Other Variables
Smoking history was defined in terms of nonsmokers, occasional smokers, and daily smokers, the latter 2 merged and considered to represent the smokers.
Education levels were divided in 3 categories by year of education: #12 years, 13 
Statistical Analyses
Kruskal-Wallis tests were used to compare continuous variables between the groups and chi-squared tests for dichotomous variables. Spearman correlations were used, with the accompanying significance tests, testing the linear relationship between disease activity before and during pregnancy and between disease activity graded from low-to-high activity on a scale from 1 to 4 and change of treatment as at least one of these options: change in medication, IBD-related surgery, or hospital admission.
Regression models were fitted to estimate associations between inadequate GWG and adverse pregnancy outcomes among mothers with IBD, using dichotomous GWG, inadequate GWG or not, or as an ordinal variable using adequate GWG as reference group. Disease activity was added as confounder in separate models. We adjusted for potential confounding by diabetes, hypertension, smoking history, maternal age, and education in all models. We report odds ratio (OR) and corresponding 95% confidence intervals (CIs).
The continuous variable GWG was split in quartiles based on the distribution of GWG among mothers with IBD: GWG ,10 kg, 10# GWG ,13 kg, 13# GWG ,17.5 kg, and GWG $17.5 kg. The 2 first quartiles were collapsed and considered to represent the lowest GWG group. In the IBD subanalyses, CD and UC were merged to increase statistical power for the associations between GWG and SGA or disease activity using GWG as an ordinal variable with adequate GWG or highest GWG group ($17.5 kg) as reference group, respectively. P values less than 0.05 were considered statistically significant. The statistical analyses were performed using the software SPSS version 20.
RESULTS
The Norwegian MoBa Cohort
The cohort comprises 215 CD and 287 UC mothers, of whom 166 CD, 217 UC mothers, and 79.125 non-IBD mothers were available for the GWG analyses.
Disease Activity Before and During Pregnancy
Of the responders to our mail-out questionnaire, 132 of 136 CD and 177 of 192 mothers with UC completed questions about disease activity (88%). Sixty-five mothers with IBD (65/309, 21%) reported flares during pregnancy with either change in medication (57/65), IBD-related hospital admission (16/65), or IBD-related surgery (5/65). There was a high correlation between disease activity 4 weeks before conceiving and disease activity during pregnancy (0.61, P , 0.001). The proportion of those who reported disease activity before pregnancy and who also reported disease activity during pregnancy was highest among those who experienced severe disease activity with sick leave (81%) compared with those who reported some disease activity, but with no consequences for daily activity (52%). Furthermore, the correlation between disease activity reported on a scale from 1 to 4 and change in treatment (change in medication, IBD-related surgery, and hospital admission) was high (0.62, P , 0.001). The proportion of those who needed change in treatment was 3-fold among those who experienced severe disease (75%) compared with those who experienced low disease activity (25%).
GWG Among IBD and Non-IBD Mothers
Demographics, mothers' disease, smoking history, and adverse pregnancy outcomes in maternal CD and UC compared with controls are listed in Table 2 .
The GWG for maternal CD varied from 216 to 43 kg, and the corresponding values for maternal UC were 22 to 37 kg. Including all BMI groups, maternal CD (34.3%) and UC (26.7%) had a higher risk of inadequate GWG compared with non-IBD mothers (19.4%) (adjusted OR ¼ 2.02, CI, 1.42-2.86 and OR ¼ 1.46, CI, 1.04-2.05, respectively).
The distribution of BMI groups did not differ between IBD and non-IBD mothers ( Mean difference in net weight gain between IBD (7.8 kg) and non-IBD (7.4 kg) with maternal inadequate GWG was 0.443 g (P ¼ 0.44).
The crude and adjusted odds for preterm birth or SGA babies among mothers with CD and UC exposed to inadequate GWG are listed in Table 4 . In these analyses, using GWG as a dichotomous variable, inadequate or not, we compared mothers with IBD who were exposed to inadequate GWG with nonexposed IBD mothers. Exposed mothers with UC and CD were associated with 5.5 and 4.5 increased risk for SGA, respectively. When disease activity was added in the separate models, the strong association between inadequate GWG and SGA among mothers with IBD did not change.
The distribution of pregnancy outcomes, mothers' disease, and sociodemographic data allocated by GWG groups among mothers with IBD are listed in Table 5 .
Using adequate GWG as a reference group did not change the strong association between inadequate GWG and SGA among women with IBD. Mothers with IBD with inadequate GWG had a 4-fold increased risk of SGA compared with mothers with IBD with adequate GWG (aOR ¼ 4.01, 95% CI, 1.39-11.88). The odds for SGA did not differ between mothers with IBD with adequate GWG and 
DISCUSSION
Searching for predictors of adverse pregnancy outcomes among women with IBD has been an important task for adequate follow-up of patients with IBD before and during pregnancy. Although disease activity has been pointed out as the strongest predictor of adverse pregnancy outcomes in IBD, 1,2 having IBD has been shown to be a risk factor on its own, independent of disease activity. 5, 6, 21 Based on the knowledge that patients with IBD are prone to weight loss in general, 15, 16 the study explored the risk of inadequate GWG and the impact of inadequate GWG on adverse pregnancy outcomes among IBD compared with non-IBD mothers.
Our findings revealed that inadequate GWG occurred significantly more often among mothers with CD (39%) and UC (33%) compared with non-IBD mothers (21%) in the normal BMI group. Furthermore, the risk of SGA was increased with a factor of 4.5 and 5.5 in mothers with CD and UC exposed to inadequate GWG (Table 4) , respectively, compared with nonexposed mothers with CD and UC.
Although disease activity contributed to reduced (low) weight gain during pregnancy, disease activity was not associated with inadequate GWG according to the IOM recommendations but similarly distributed among those with adequate (35.1%) and inadequate GWG (36.8%). Furthermore, when disease activity was added to the regression models (Table 4) , it did not influence the association between inadequate GWG and adverse pregnancy outcomes, suggesting inadequate GWG as an independent predictor of SGA.
The most commonly presenting feature of newly diagnosed IBD children is weight loss, especially in children with CD (60%), but also in UC (35%). 14 Weight loss is also usually observed during relapse of a disease. 22 Many factors could explain why mothers with IBD are more exposed to inadequate weight gain during pregnancy compared with mothers without IBD. Enteric loss of nutrition and malabsorption due to chronic diarrhea, inflammation, and bowel resections are contributing factors of malnutrition in patients with IBD. However, reduced food intake, to minimize symptoms of abdominal pain and diarrhea, has been suggested as one of the main mechanisms to low caloric-protein intake and micronutrition deficiencies in IBD, even in remission. 16 One study showed that approximately 33% of patients with IBD avoid dairy products in remission. 17 Protein intake from diary sources, especially in early period of pregnancy, has been shown to correlate with birth weight both in developed and developing countries. [23] [24] [25] [26] Furthermore, anemia, which occurs in approximately 25% of the patients with IBD, 27, 28 has been linked to adverse pregnancy outcomes such as preterm birth and low birth weight. 29, 30 An earlier MoBa study revealed a link between SGA and inadequate GWG in the general population in Norway. 11 The present MoBa-IBD study showed that inadequate GWG had a higher impact on adverse pregnancy outcomes among IBD compared with non-IBD mothers. Maternal CD with inadequate GWG reduced the risk of preterm birth with 34% per kg weight gain compared with 4% in non-IBD mothers with inadequate GWG. Furthermore, mothers with IBD with inadequate GWG had twice as high risk for SGA babies compared with non-IBD mothers with inadequate GWG. This vulnerability of preterm birth and SGA among mothers with IBD exposed to inadequate GWG compared with exposed non-IBD mothers cannot be explained by lower net weight gain among mothers with IBD (mean difference 0.443 g, P ¼ 0.44). The explanation might be that mothers with IBD are prone to malnutrition before conceiving and in the periconceptional and early pregnancy periods. Nutrition-related influences on adverse pregnancy outcomes are captured especially in this period, the stage of rapid placental development. [31] [32] [33] We know little about the risk profile of SGA associated with weight gain at different stages of pregnancy in this study because GWG was defined as the difference between prepregnancy weight and weight at birth. However, several investigations have revealed that GWG pattern and the maternal body composition, body water, lean mass, and fat mass during pregnancy influence the birth size of the infants. 34 Increases in maternal lean mass and body water have been associated with higher birth weight in the offspring, whereas increases in maternal fat mass has been associated with maternal fat retention postpartum. 35 Furthermore, greater GWG in the first trimester has been associated with higher infant birth weight. 36 Although monitoring GWG in the first trimester appeared to be important for the fetal growth, Fattah et al 37 showed that the mean body composition and mean maternal weight remain unchanged during the first trimester among the 1000 pregnant whites who were included in that study. On this background, repeat ultrasound measurements for assessing the relationship between fetal growth and maternal weight might be important for optimizing pregnancy outcomes in IBD. Identifying SGA directly by ultrasound midpregnancy would allow intervention in the second and third trimester in these by definition high-risk pregnancies. 38 A meta-analysis by Jie Dong et al 39 demonstrated lower BMI among patients with CD compared with controls, unlike this study. The distribution of BMI groups did not differ between controls and mothers with IBD in the MoBa cohort in accordance with data from adult and pediatric studies. 40, 41 Flores et al showed that obese patients with IBD received less anti-tumor necrosis factor alpha therapy and experienced less surgery and IBDrelated hospitalization than their nonobese counterparts, suggesting less severe disease in obese patients with IBD. Although the trend of obesity among patients with IBD, CD less than UC, reflects the obesity epidemic in the general population, a pediatric study suggested that weight or BMI might mask deficits in lean tissue, as a proxy of malnutrition, in CD children with normal or overweight BMI. 42, 43 A significant higher proportion of mothers with UC (26.6%) reported disease activity during pregnancy defined as change of medication, IBD-related hospital admission, or surgery during pregnancy compared with mothers with CD (13.6%). Maternal UC with inadequate GWG (15/45, 33 .3%) demonstrated a trend for disease activity compared with maternal CD with inadequate GWG (6/35, 17.1%) (P ¼ 0.10), which might suggest that inadequate GWG in patients with UC is associated with disease activity. A recently published study reflects a similar association between disease activity and malnutrition only in UC, by comparing the nutritional status and resting energy expenditure between hospitalized patients with CD and UC. 44 The authors did not find any differences in nutritional parameters and energy metabolism between patients with CD and UC, but resting energy expenditure correlated with disease activity only in UC.
Malnutrition in patients with CD could be explained by several factors, unrelated to disease activity, such as small bowel resections and transmural inflammation. Al-Jaouni et al 45 showed altered metabolism with higher resting energy expenditure in combination with increased fat oxidation in patients with CD with active disease and in remission.
Disease activity was neither associated with adverse pregnancy outcomes in mothers with IBD in this cohort nor with inadequate GWG in accordance with the IOM recommendations. However, our study revealed disease activity as a risk factor for reduced GWG. The risk of low GWG (,13 kg) compared with high GWG (.17.5 kg) increased 3-fold among mothers with IBD with flares compared with those without flares.
We speculate, based on our results, that inadequate GWG has been the "hidden link" or the mediator between IBD and adverse pregnancy outcomes in earlier investigations where IBD was revealed as an independent risk factor for perinatal complications. Furthermore, the reason why factors such as disease activity, bowel resections, and ileal disease [1] [2] [3] have been pointed out as predictors of adverse pregnancy outcomes in IBD might be that they all are possible contributors to lower GWG.
Two earlier investigations have included net GWG as a risk factor for adverse pregnancy outcomes among mothers with IBD, 18, 19 both relatively small retrospective designed studies from tertiary university level. Similar to this study, the Finish study by Raatikainen et al showed that mothers with IBD gain less weight during pregnancy compared with controls. The Israeli study by Oron et al included 28 maternal UC and 47 maternal CD with matched controls. 18 The authors demonstrated that GWG ,12 kg and disease exacerbation were significantly associated with adverse pregnancy outcomes.
The strengths of this study include the large and nationwide sample size, the linkage to the national birth registry, and the use of GWG according to the IOM recommendations to correct for BMI groups instead of net GWG. We were also able to include relevant potential confounder variables in our analyses.
Limitations of this study include the fact that weight change and prepregnant weight class were based on self-reported weight. Epidemiological studies on GWG have shown that women, especially women who are overweight or obese, underestimate their prepregnant weight, which might place them in a lower BMI group with overestimated GWG. 46 However, being placed in excessive instead of adequate GWG group in the normal and overweight group, respectively, has probably not influenced the association between inadequate GWG and adverse pregnancy outcomes in this study because we used GWG as a dichotomous variable, inadequate or not, merging adequate and excessive GWG in the same group. Furthermore, because the distribution of SGA was similar in adequate and excessive GWG groups among the mothers with IBD, a possible misclassification has not inflated the association between inadequate GWG and SGA.
Another limitation was the self-reported disease activity during pregnancy several years after relevant delivery and the assessment of disease activity. The questionnaire for this study was mailed out 5 to 14 years after the relevant pregnancy. This time lag is associated with recall bias, and the data of disease activity must therefore be treated with caution. Trying to minimize the effect of recall bias, disease activity was defined as fulfillment of at least one of 3 options: change in medications, IBD-related surgery, or hospital admission during pregnancy. These proxies for disease activity, usually used in retrospective studies and register studies, 8, 9, 18 do not represent objective markers and do not include mild and moderate disease activity. However, we believe that these events during pregnancy would be easier to recall compared with grading level of disease from mild-to-severe disease. The mothers with IBD were asked to report disease activity in 2 ways: by symptoms scale, ranging from no symptoms to severe symptoms with sick leave as a consequence, and by change in medication, IBD-related surgery or hospital admission. Regarding change of medication, they were only asked to report intensified treatment, without reporting treatment duration or response to treatment. There was a high correlation between reported severe disease and change of treatment, and we believe that this consistency of reported disease activity limited the chances of information bias.
Having in mind that we have only caught mothers with IBD with severe disease activity, we did find a low rate of flares before pregnancy and similar throughout pregnancy, in line with earlier population-based studies. 5, 47 The number of mothers with IBD included in the analyses was relatively low, 383 mothers with IBD of whom 115 had inadequate GWG. The significant higher risk of inadequate GWG among mothers with IBD compared with non-IBD mothers appeared in the normal BMI group. Although the number of mothers with IBD with inadequate GWG was low, 46/117 with CD and 50/149 with UC compared with 11,518/52,207 non-IBD mothers in the normal BMI group, the uncertainty inherent to the risk estimates showed in the CIs were relatively narrow, which made us reasonably sure that this was a true effect.
Most of the analyses were fitted separately for CD and UC in this study. However, the phenotypes were merged in the IBD subanalyses, using GWG as an ordinal variable, to increase statistical power. Because of limited number, CD and UC were also combined exploring the risk of SGA among IBD compared with non-IBD mothers exposed to inadequate GWG.
In conclusion, this study revealed, for the first time to our knowledge, that mothers with IBD are more prone to inadequate GWG compared with non-IBD mothers, and when exposed to inadequate GWG, they are more vulnerable to adverse pregnancy outcomes. Inadequate GWG was demonstrated as a strong independent predictor of SGA among mothers with IBD. Disease activity contributed to reduced weight gain during pregnancy but did not influence the association between inadequate GWG and adverse pregnancy outcomes.
Our findings suggest careful follow-up of caloric-protein intake in patients with IBD before pregnancy and during pregnancy, having in mind that the first trimester is a risk period difficult to interpret, due to low weight gain, if any at all in this period. Inadequate GWG should be considered as a risk factor on its own or as a marker of disease activity leading to disease activity measurement and nutritional correction of calorie-protein intake and micronutrition deficiencies.
